Dengue vaccine clinical trials in India - An opportunity to inform the global response to a re-emerging disease challenge

被引：2

作者：

Fauci, Anthony ^{[1
]}

Erbelding, Emily ^{[2
]}

Whitehead, Stephen ^{[3
]}

Cassetti, M. Cristina ^{[4
]}

Handley, F. Gray ^{[5
]}

Gupta, Ranjan ^{[6
]}

机构：

[1] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[2] NIAID, Div Microbiol & Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[3] NIAID, Lab Infect Dis, NIH, Bethesda, MD 20892 USA

[4] NIAID, Virol Branch, Div Microbiol & Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[5] NIAID, Off Director, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[6] NIAID, Off Global Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

来源：

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2019年 / 84卷

关键词：

PATHOGENESIS; ENHANCEMENT; FEVER;

D O I：

10.1016/j.ijid.2019.03.016

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：S4 / S6

页数：3

共 29 条

[1] The global distribution and burden of dengue [J].

Bhatt, Samir ;

Gething, Peter W. ;

Brady, Oliver J. ;

Messina, Jane P. ;

Farlow, Andrew W. ;

Moyes, Catherine L. ;

Drake, John M. ;

Brownstein, John S. ;

Hoen, Anne G. ;

Sankoh, Osman ;

Myers, Monica F. ;

George, Dylan B. ;

Jaenisch, Thomas ;

Wint, G. R. William ;

Simmons, Cameron P. ;

Scott, Thomas W. ;

Farrar, Jeremy J. ;

Hay, Simon I. .

NATURE, 2013, 496 (7446) :504-507

[2] Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine [J].

Coudeville, Laurent ;

Baurin, Nicolas ;

L'Azou, Maina ;

Guy, Bruno .

VACCINE, 2016, 34 (50) :6426-6435

[3]

Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0

[4]

Gupta N, 2012, INDIAN J MED RES, V136, P373

[5] A recombinant live attenuated tetravalent vaccine for the prevention of dengue [J].

Guy, Bruno ;

Noriega, Fernando ;

Ochiai, R. Leon ;

L'azou, Maina ;

Delore, Valentine ;

Skipetrova, Anna ;

Verdier, Francois ;

Coudeville, Laurent ;

Savarino, Stephen ;

Jackson, Nicholas .

EXPERT REVIEW OF VACCINES, 2017, 16 (07) :671-683

[6] Dengue vaccine: hypotheses to understand CYD-TDV-induced protection [J].

Guy, Bruno ;

Jackson, Nicholas .

NATURE REVIEWS MICROBIOLOGY, 2016, 14 (01) :45-54

[7] From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine [J].

Guy, Bruno ;

Barrere, Beatrice ;

Malinowski, Claire ;

Saville, Melanie ;

Teyssou, Remy ;

Lang, Jean .

VACCINE, 2011, 29 (42) :7229-7241

[8] Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease [J].

Hadinegoro, S. R. ;

Arredondo-Garcia, J. L. ;

Capeding, M. R. ;

Deseda, C. ;

Chotpitayasunondh, T. ;

Dietze, R. ;

Ismail, H. I. Hj Muhammad ;

Reynales, H. ;

Limkittikul, K. ;

Rivera-Medina, D. M. ;

Tran, H. N. ;

Bouckenooghe, A. ;

Chansinghakul, D. ;

Cortes, M. ;

Fanouillere, K. ;

Forrat, R. ;

Frago, C. ;

Gailhardou, S. ;

Jackson, N. ;

Noriega, F. ;

Plennevaux, E. ;

Wartel, T. A. ;

Zambrano, B. ;

Saville, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) :1195-1206

[9] Protective and immunological behavior of chimeric yellow fever dengue vaccine [J].

Halstead, Scott B. ;

Russell, Philip K. .

VACCINE, 2016, 34 (14) :1643-1647

[10]

Kalayanarooj Siripen, 2011, Trop Med Health, V39, P83, DOI 10.2149/tmh.2011-S10

← 1 2 3 →